Research Archive — Page 116 of 135
-
May 9, 2018
Study finds generic options offer limited savings for expensive drugs
Generic drug options did not reduce prices paid for the cancer therapy imatinib (Gleevec), according to a Health Affairs study released this week. -
May 9, 2018
Putting the brakes on sepsis
An enzyme called PTEN reduces inflammatory signaling and mortality in sepsis, suggesting it may be a good therapeutic target for this life-threatening complication of infection. -
May 7, 2018
Records point to drug-drug interaction
Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage. -
May 4, 2018
New breast cancer targets
A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer. -
May 3, 2018
Understanding HDL structure
Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function. -
May 3, 2018
Gene study spots clues to heart risk for statin patients
A Vanderbilt-led research team has discovered genetic variations that increase the risk of heart attack even when patients are receiving a statin drug like Lipitor or Crestor to lower their blood cholesterol. -
May 1, 2018
Looking beyond the ‘magic bullet’ approach to drug discovery
Vanderbilt scientists have developed a new process that can rapidly and inexpensively identify personalized cancer drugs derived from nature.